Movatterモバイル変換


[0]ホーム

URL:


AR012443A1 - NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES - Google Patents

NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES

Info

Publication number
AR012443A1
AR012443A1ARP980101743AAR012443A1AR 012443 A1AR012443 A1AR 012443A1AR P980101743 AARP980101743 AAR P980101743AAR 012443 A1AR012443 A1AR 012443A1
Authority
AR
Argentina
Prior art keywords
alkyl
4alkyl
formula
group
carboxamids
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Uriach & Cia Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cia Sa JfiledCriticalUriach & Cia Sa J
Publication of AR012443A1publicationCriticalpatent/AR012443A1/en

Links

Classifications

Landscapes

Abstract

Translated fromSpanish

Compuestos de formula I donde: uno de Y1 o Y2 representa N y el otro representa NR5, O o S, o bien uno de Y1 o Y2 representa S y el otro representaCR5, donde R5 representa hidrogeno o C1-4 alquilo; m representa 0, 1 o 2; R1 y R3 representa hidrogeno, C1-6 alquilo, C2-6 alquenilo, C2-6 alquinilo, C1-6alcoxi, C1-6 haloalquilo, C3-7 cicloalquilo, C3-7 cicloalquilC1-4 alquilo, arilo, arilC1-4 alquilo, arilC1-4 alcoxi, arilC3-7 cicloalquilo, heteroarilo,heteroarilC1-4 alquilo, R6SO2NR2-,R6CONR2-, R6OCONR2-, R2R7NCONR2-, R2R7N-, R6SO2NR2C1-4 alquilo, R6CONR2C1-4 alquilo, R6OCONR2C1-4 alquilo-R2R7NCONR2C1-4 alquilo, R6SO2C1-4 alquilo, R2R7NSO2C1-4 alquilo, R2R7NCOC1-4 alquilo, R6COC1-4 alquilo, R7OOCC1-4 alquilo, R6OC1-4 alquilo, o R2R7NC1-4alquilo; A representa CO-2 alquileno opcionalmente sustituido; R2 representa hidrogeno n C1-4 alquilo; B representa carboxi o un éster o amidametabolicamente lábil del mismos; y R4 representa un grupo de formula (i) o (ii). R6 representa C1-6 alquilo, C2-6 alquenilo, C2-6 alquinilo, C1-6haloalquilo, C1-4 alcoxiC1-4 alquilo, C1-7 cicloalquilo, C3-7 cicloalquilC1-4 alquilo, arilo, arilC1-4, alquilo, arilcarboniloC1-4, alquilo, heteroarilo, oheteroalrilC1-4, alquilo, R7 representa halogeno o cualquiera de los significados descitos para R6, R8 representa halogeno o C1-4 alquilo; prepresenta 1 o 2. X1 representa un grupo de formula: N,CH>N-CH2-, o >CH-CH2-; X2 representa un grupo de formula: N,CH-CH2-N<, -CH2-<CH,-NH-<CH o -O-<CH;X3 representa N o CH, con la condicion de que cuando X3 sea N no puede ser un grupo: N, -CH2-<N, -NH-<CH o -O-<CH; uno de Z1 o Z2 representa Z y el otrorepresenta CH2, con la condicion de que cuando X3 representa N, entonces Z2ha de ser CH2; Z representa un grupo de formula: HN<, C1-6 alquilo <N.Compounds of formula I where: one of Y1 or Y2 represents N and the other represents NR5, O or S, or one of Y1 or Y2 represents S and the other represents CR5, where R5 represents hydrogen or C1-4 alkyl; m represents 0, 1 or 2; R1 and R3 represent hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6haloalkyl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl, aryl, arylC1-4alkyl, arylC1-4alkoxy, arylC3-7 cycloalkyl, heteroaryl, heteroarylC1-4alkyl, R6SO2NR2-, R6CONR2-, R6OCONR2-, R2R7NCONR2-, R2R7N-, R6SO2NR2C1-4R2C2R2C1R2C1R2C1R2C2 alkyl, R6SO2C1-4 alkyl, R2R7NSO2C1-4 alkyl, R2R7NCOC1-4 alkyl, R6COC1-4 alkyl, R7OOCC1-4 alkyl, R6OC1-4 alkyl, or R2R7NC1-4alkyl; A represents CO-2 optionally substituted alkylene; R2 represents hydrogen n C1-4 alkyl; B represents carboxy or an ester or amidametabolically labile thereof; and R4 represents a group of formula (i) or (ii). R6 represents C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6haloalkyl, C1-4alkoxyC1-4alkyl, C1-7cycloalkyl, C3-7cycloalkylC1-4alkyl, aryl, arylC1-4alkyl, C 1-4 arylcarbonyl, alkyl, heteroaryl, C 1-4 heteroaryl, alkyl, R7 represents halogen or any of the meanings for R6, R8 represents halogen or C1-4 alkyl; it represents 1 or 2. X1 represents a group of formula: N, CH> N-CH2-, or> CH-CH2-; X2 represents a group of the formula: N, CH-CH2-N <, -CH2- <CH, -NH- <CH or -O- <CH; X3 represents N or CH, with the proviso that when X3 is N there is no it can be a group: N, -CH2- <N, -NH- <CH or -O- <CH; one of Z1 or Z2 represents Z and the other represents CH2, with the proviso that when X3 represents N, then Z2 must be CH2; Z represents a group of the formula: HN <, C1-6 alkyl <N.

ARP9801017431997-04-161998-04-15 NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINESAR012443A1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
ES97008071997-04-16

Publications (1)

Publication NumberPublication Date
AR012443A1true AR012443A1 (en)2000-10-18

Family

ID=8298973

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ARP980101743AR012443A1 (en)1997-04-161998-04-15 NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES

Country Status (3)

CountryLink
AR (1)AR012443A1 (en)
AU (1)AU7526398A (en)
WO (1)WO1998046599A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TWI290136B (en)*2000-04-052007-11-21Daiichi Seiyaku CoEthylenediamine derivatives
DE10029077A1 (en)*2000-06-132001-12-20Bayer AgNew heterocyclic-substituted thiazole derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
CA2489095A1 (en)2002-06-172003-12-24Sunesis Pharmaceuticals, Inc.Aspartyl protease inhibitors
US7115652B2 (en)2002-06-172006-10-03Sunesis Pharmaceuticals, Inc.Aspartyl protease inhibitors
GB0230162D0 (en)*2002-12-242003-02-05Metris Therapeutics LtdCompounds useful in inhibiting angiogenesis
DK1682537T3 (en)2003-11-052012-07-09Sarcode Bioscience Inc Cell adhesion modulators
AU2005230846A1 (en)2004-03-312005-10-20Lexicon Pharmaceuticals, Inc.2-aminomethylthiazole-5-carboxamides as protein kinase modulators
CA2960117C (en)2005-05-172018-01-30Sarcode Bioscience Inc.Lfa-1 antagonists for the treatment of eye disorders
GB0518494D0 (en)*2005-09-092005-10-19Argenta Discovery LtdThiazole compounds
EP2112880A4 (en)*2006-12-142011-12-21Merck Sharp & Dohme ACYL-BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PROCESSING METHODS
EP3167886B1 (en)2007-10-192020-08-05Novartis AGCompositions and methods for treatment of macular edema
US8080562B2 (en)2008-04-152011-12-20Sarcode Bioscience Inc.Crystalline pharmaceutical and methods of preparation and use thereof
WO2011050175A1 (en)2009-10-212011-04-28Sarcode CorporationCrystalline pharmaceutical and methods of preparation and use thereof
CA2803880C (en)*2010-06-282018-09-25President And Fellows Of Harvard CollegeCompounds for the inhibition of cellular proliferation
SI3715345T1 (en)2012-07-252024-07-31Bausch + Lomb Ireland Limited PREPARATION OF THE LFA-1 INHIBITOR
ES2694299T3 (en)2013-02-072018-12-19Heptares Therapeutics Limited Piperidin-1-yl and azepin-1-yl carboxylates as agonists of the M4 muscarinic receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE4124942A1 (en)*1991-07-271993-01-28Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
WO1994002472A1 (en)*1992-07-151994-02-03Taisho Pharmaceutical Co., Ltd.Thiazoline derivative
AU692439B2 (en)*1993-03-291998-06-11Zeneca LimitedHeterocyclic compounds as platelet aggregation inhibitors
DE19524765A1 (en)*1995-07-071997-01-09Boehringer Mannheim Gmbh New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds

Also Published As

Publication numberPublication date
WO1998046599A1 (en)1998-10-22
AU7526398A (en)1998-11-11

Similar Documents

PublicationPublication DateTitle
AR012443A1 (en) NEW CARBOXAMIDS AS INHIBITORS OF THE PLATELET AGGREGATION, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE MANUFACTURE OF MEDICINES
AR022229A1 (en) TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF THE SAME TO PREPARE SUCH COMPOSITION
AR045901A1 (en) SPECIFIC GLUCOCORTICOESTEROIDS WITH ANTI-INFLAMMATORY AND ANTIALERGIC ACTIVITIES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCEDURES FOR THEIR PREPARATION,
AR025975A1 (en) CHEMICAL COMPOUNDS.
AR048641A1 (en) ARTH- OR HETEROARILAMIDE ORTHOSUSTITUTED COMPOUNDS USEFUL AS ANTAGO-NISTAS OF THE PROSTAGLANDINAS E2 RECEIVER; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICAME
DE60118225D1 (en) CHINOLIN AND CHINAZOLINE DERIVATIVES AND THEIR USE AS FARNESYL TRANSFERASE INHIBITORS
ES2132351T3 (en) COMPOSED WITH A SULFAMOIL AND AMIDINE GROUP, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
NO20023933D0 (en) New connections
AR036248A1 (en) DERIVATIVES OF 2H-PIRIDAZIN-3-ONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND A PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
MA27664A1 (en) MEDIUM CHAIN FATTY ACIDS, GLYCERIDES AND THE LIKE USED AS ERYTHROPOSIS STIMULATORS
AR013693A1 (en) NEW PIPERIDINES AND PIPERAZINAS AS INHIBITORS OF THE PLAQUETARY AGREGATION
DOP2022000015A (en) 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PROAPOPTOTIC AGENTS
AR039936A1 (en) PHARMACEUTICAL FORMULATION OF MODIFIED LIBERATION
AR060438A1 (en) 2- (PIRIDIN-2-IL) - PYRIMIDINS AS FUNGICIDES.
AR036472A1 (en) DERIVATIVES OF AZETIDINE, PROCEDURES FOR PREPARATION AND EMPLOYMENT AS PESTICIDE AGENTS
SE0200919D0 (en) Chemical compounds
BR0111678A (en) Medicinal compositions containing propenone derivatives
SE0101038D0 (en) Novel compounds
AR029468A1 (en) DERIVATIVES OF N-MARKET AMINO ACIDS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CO5221057A1 (en) PESTICIATED COMPONENTS AND COMPOSITIONS
AR027352A1 (en) NEW POSITIVE ALOSTERIC MODULATORS OF AMPA RECEPTORS (PAARM), PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICATIONS
MX9300306A (en) BENZMIDAZOLES MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
AR032712A1 (en) A MESILATE OF PHENYLPIPERAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
AR033651A1 (en) DERIVATIVES OF PYRIMIDINE-2,4,6-TRIONA, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR030002A1 (en) BENZOTIADIAZINE COMPOUNDS A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

[8]ページ先頭

©2009-2025 Movatter.jp